Neuberger Berman Group LLC reduced its stake in shares of Ambev S.A. (NYSE:ABEV - Free Report) by 95.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,023 shares of the company's stock after selling 495,704 shares during the quarter. Neuberger Berman Group LLC's holdings in Ambev were worth $54,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. GAMMA Investing LLC raised its stake in Ambev by 468.4% during the 1st quarter. GAMMA Investing LLC now owns 10,998 shares of the company's stock valued at $26,000 after purchasing an additional 9,063 shares during the last quarter. Perigon Wealth Management LLC acquired a new position in shares of Ambev in the 1st quarter valued at $27,000. U.S. Capital Wealth Advisors LLC acquired a new position in shares of Ambev in the 1st quarter valued at $28,000. M&T Bank Corp acquired a new position in shares of Ambev in the 1st quarter valued at $30,000. Finally, R Squared Ltd acquired a new position in shares of Ambev in the 1st quarter valued at $33,000. 8.13% of the stock is currently owned by institutional investors and hedge funds.
Ambev Price Performance
Shares of Ambev stock traded up $0.0350 during mid-day trading on Friday, reaching $2.2250. 6,023,363 shares of the stock were exchanged, compared to its average volume of 32,685,162. The company has a market cap of $35.06 billion, a price-to-earnings ratio of 13.91, a price-to-earnings-growth ratio of 2.39 and a beta of 0.74. The company has a current ratio of 1.11, a quick ratio of 0.80 and a debt-to-equity ratio of 0.02. The firm has a 50-day simple moving average of $2.33 and a 200 day simple moving average of $2.31. Ambev S.A. has a fifty-two week low of $1.76 and a fifty-two week high of $2.63.
Ambev (NYSE:ABEV - Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported $0.03 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.03. The business had revenue of $3.59 billion during the quarter, compared to analysts' expectations of $21.84 billion. Ambev had a net margin of 16.18% and a return on equity of 15.39%. On average, sell-side analysts predict that Ambev S.A. will post 0.18 EPS for the current fiscal year.
Ambev Increases Dividend
The business also recently disclosed a -- dividend, which will be paid on Tuesday, October 14th. Shareholders of record on Monday, August 11th will be issued a dividend of $0.023 per share. The ex-dividend date of this dividend is Monday, August 11th. This represents a yield of 660.0%. This is an increase from Ambev's previous -- dividend of $0.02. Ambev's payout ratio is currently 25.00%.
Analyst Upgrades and Downgrades
ABEV has been the subject of a number of recent research reports. Hsbc Global Res upgraded shares of Ambev to a "hold" rating in a research note on Friday, August 1st. Barclays increased their price objective on shares of Ambev from $2.00 to $2.50 and gave the company an "equal weight" rating in a research note on Monday, May 12th. HSBC restated a "hold" rating on shares of Ambev in a research note on Friday, August 1st. Finally, UBS Group dropped their price objective on shares of Ambev from $2.50 to $2.20 and set a "neutral" rating for the company in a research note on Wednesday. Six analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Ambev has an average rating of "Reduce" and an average target price of $2.35.
View Our Latest Stock Analysis on ABEV
Ambev Profile
(
Free Report)
Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.
See Also

Before you consider Ambev, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.
While Ambev currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.